Cargando…

Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization

PURPOSE: To report the case of a patient with unilateral idiopathic macular telangiectasia (IMT) associated with type 3 neovascularization. METHODS: Observational case report. RESULTS: We describe a case of an 85-year-old woman who presented at our department with a gradual vision loss in her left e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilleul, Julien, Querques, Giuseppe, Capuano, Vittorio, Miere, Alexandra, Srour, Mayer, Souied, Eric H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337169/
https://www.ncbi.nlm.nih.gov/pubmed/25759660
http://dx.doi.org/10.1159/000369124
_version_ 1782358574247182336
author Tilleul, Julien
Querques, Giuseppe
Capuano, Vittorio
Miere, Alexandra
Srour, Mayer
Souied, Eric H.
author_facet Tilleul, Julien
Querques, Giuseppe
Capuano, Vittorio
Miere, Alexandra
Srour, Mayer
Souied, Eric H.
author_sort Tilleul, Julien
collection PubMed
description PURPOSE: To report the case of a patient with unilateral idiopathic macular telangiectasia (IMT) associated with type 3 neovascularization. METHODS: Observational case report. RESULTS: We describe a case of an 85-year-old woman who presented at our department with a gradual vision loss in her left eye (LE). Her best-corrected visual acuity (BCVA) was 20/200 in the LE. Fundus examination showed 2 small hemorrhages located nasally to the LE fovea, as well as lipid exudates. Fluorescein angiography revealed early hyperfluorescence corresponding to the dilated capillaries. Spectral-domain optical coherence tomography (SD-OCT) showed several microaneurysms within the inner retinal layers. Late indocyanine green angiography revealed a focal hyperfluorescence corresponding to a type 3 neovascularization. No signs of IMT or type 3 neovascularization were detected in the right eye. Based on these findings, the patient was diagnosed with type 1 IMT and coincident type 3 neovascularization. The LE was treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections. Twenty-four months later, SD-OCT revealed regression of the exudative signs, and LE BCVA improved to 20/100. CONCLUSION: We describe the case of an unusual association between older-onset IMT and type 3 neovascularization, and subsequent regression by anti-VEGF injections. We propose a new IMT subtype called type 1C for this association. Further research must be done in order to establish the pathophysiologic mechanism and likelihood of this association.
format Online
Article
Text
id pubmed-4337169
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-43371692015-03-10 Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization Tilleul, Julien Querques, Giuseppe Capuano, Vittorio Miere, Alexandra Srour, Mayer Souied, Eric H. Case Rep Ophthalmol Published online: November, 2014 PURPOSE: To report the case of a patient with unilateral idiopathic macular telangiectasia (IMT) associated with type 3 neovascularization. METHODS: Observational case report. RESULTS: We describe a case of an 85-year-old woman who presented at our department with a gradual vision loss in her left eye (LE). Her best-corrected visual acuity (BCVA) was 20/200 in the LE. Fundus examination showed 2 small hemorrhages located nasally to the LE fovea, as well as lipid exudates. Fluorescein angiography revealed early hyperfluorescence corresponding to the dilated capillaries. Spectral-domain optical coherence tomography (SD-OCT) showed several microaneurysms within the inner retinal layers. Late indocyanine green angiography revealed a focal hyperfluorescence corresponding to a type 3 neovascularization. No signs of IMT or type 3 neovascularization were detected in the right eye. Based on these findings, the patient was diagnosed with type 1 IMT and coincident type 3 neovascularization. The LE was treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections. Twenty-four months later, SD-OCT revealed regression of the exudative signs, and LE BCVA improved to 20/100. CONCLUSION: We describe the case of an unusual association between older-onset IMT and type 3 neovascularization, and subsequent regression by anti-VEGF injections. We propose a new IMT subtype called type 1C for this association. Further research must be done in order to establish the pathophysiologic mechanism and likelihood of this association. S. Karger AG 2014-11-05 /pmc/articles/PMC4337169/ /pubmed/25759660 http://dx.doi.org/10.1159/000369124 Text en Copyright © 2014 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published online: November, 2014
Tilleul, Julien
Querques, Giuseppe
Capuano, Vittorio
Miere, Alexandra
Srour, Mayer
Souied, Eric H.
Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
title Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
title_full Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
title_fullStr Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
title_full_unstemmed Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
title_short Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
title_sort type 1 idiopathic macular telangiectasia associated with type 3 neovascularization
topic Published online: November, 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337169/
https://www.ncbi.nlm.nih.gov/pubmed/25759660
http://dx.doi.org/10.1159/000369124
work_keys_str_mv AT tilleuljulien type1idiopathicmaculartelangiectasiaassociatedwithtype3neovascularization
AT querquesgiuseppe type1idiopathicmaculartelangiectasiaassociatedwithtype3neovascularization
AT capuanovittorio type1idiopathicmaculartelangiectasiaassociatedwithtype3neovascularization
AT mierealexandra type1idiopathicmaculartelangiectasiaassociatedwithtype3neovascularization
AT srourmayer type1idiopathicmaculartelangiectasiaassociatedwithtype3neovascularization
AT souiederich type1idiopathicmaculartelangiectasiaassociatedwithtype3neovascularization